STAGE II RENAL CELL CANCER AJCC V8
Clinical trials for STAGE II RENAL CELL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE II RENAL CELL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE II RENAL CELL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo before kidney surgery shows promise in early trial
Disease control Not yet recruitingThis early-phase trial is testing whether giving two immunotherapy drugs (botensilimab and balstilimab) before surgery can help treat high-risk clear cell kidney cancer that hasn't spread. About 16 adults will receive the drugs before having their kidney tumor removed. The main g…
Matched conditions: STAGE II RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC
-
Gut bacteria boosts immunotherapy to fight kidney cancer recurrence?
Disease control Not yet recruitingThis phase 2 trial tests whether adding a live bacteria product called CBM588 to the standard immunotherapy drug pembrolizumab can help prevent kidney cancer from coming back after surgery. About 62 adults with high-risk kidney cancer will receive either pembrolizumab alone or pe…
Matched conditions: STAGE II RENAL CELL CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 01, 2026 17:56 UTC